Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00532051 · ClinicalTrials.gov registry record
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
A clinical trial of Cataract, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- 690
- Enrollment target
- 1
- Study location
NCT00532051: Recruiting study of Cataract, sponsored by Oregon Health and Science University.
NCT00532051 is a study of Cataract that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 690 participants, above the 220-participant average among 83 other Cataract trials with a reported enrollment target (214% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00532051, a study of Cataract, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- 690 participants
- Enrollment target
- 1
- Study location
Study Summary
The long-term goal of this project is to utilize very high-speed optical coherence tomography (OCT) technology to guide surgical treatments of corneal diseases. OCT is well known for its exquisite resolution, but until recently it has not had sufficient speed to capture the shape of the cornea because of eye motion during OCT scanning. The development of Fourier-domain (FD) OCT technology has made the requisite speed possible. The objective of this project is to develop methods for imaging the cornea with an FD-OCT system that will precisely measure corneal shape and use this information to guide surgery. Cataract surgery in patients with previous laser vision correction often leads to significant near- or far-sightedness, a problem that could be resolved by using a more accurate intraocular lens power selection formula based on the measurement of corneal refractive power with OCT.
Conditions Studied
Interventions
- DEVICE OCT measurements
Study Locations (1)
Oregon
- Casey Eye Institute, Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 690 participants |
| Start Date | 2011-04 |
| Est. Completion | 2026-07 |
What NCT00532051 shows while recruiting
NCT00532051 is an observational study that tracks outcomes without assigning an intervention. The registered 690 participants enrollment target is mid-sized for trials with a published cap, above the 220-participant average among 83 other Cataract trials with a reported enrollment target (214% higher).
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which OCT measurements is the first listed.
NCT00532051 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT00532051 about?
NCT00532051 is a clinical study titled "Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography". The long-term goal of this project is to utilize very high-speed optical coherence tomography (OCT) technology to guide surgical treatments of corneal diseases. OCT is well known for its exquisite resolution, but until recently it has not had sufficient speed to capture the shape of the cornea becau...
What is the current status of trial NCT00532051?
This trial is currently recruiting. The enrollment target is 690 participants. The study started on 2011-04. Estimated completion is 2026-07.
What conditions does trial NCT00532051 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT00532051?
The interventions under investigation include: OCT measurements (DEVICE).
Who is sponsoring clinical trial NCT00532051?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00532051 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00532051's enrollment target sits among peer trials
690 4th of 83 higher than 80 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
RECRUITING
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
RECRUITING · Phase 1
-
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
RECRUITING · Phase 3
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05184335 · 690 participants · Phase 3
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- NCT07221149 · 690 participants · Phase 2
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- NCT07382167 · 692 participants · Phase 3
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
- NCT05750654 · 688 participants · NA
Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia